Standardized Branding of Disposable Vaping Devices Reduces Young People's Interest
By Lori Solomon HealthDay Reporter
FRIDAY, May 23, 2025 -- Standardizing the color and branding of disposable vaping devices reduces young people’s interest in trying them, according to a study published online May 20 in Tobacco Control.
Harry Tattan-Birch, Ph.D., from University College London, and colleagues estimated the impact of standardizing the color and branding of disposable vaping devices on young people’s interest in trying them compared to branded disposable vapes. The analysis included survey responses from 16- to 29-year-olds in Canada, England, and the United States in 2023 (15,259 individuals).
The researchers found that a greater proportion of participants reported "no interest in trying" the white standardized vapes versus the branded vapes (67.1 versus 62.8 percent; adjusted risk ratio [aRR], 1.127). The impact of standardization on those reporting no interest was greater for those who had in the past 30 days only smoked (47.5 versus 37.5 percent; aRR, 1.287), only vaped (19.9 versus 16.4 percent; aRR, 1.220), dual used (13.5 versus 9.5 percent; aRR, 1.420), or formerly vaped/smoked (72.6 versus 65.0 percent; aRR, 1.119) compared with those who had never smoked or vaped. The impact was also greater in the oldest age group.
"There may be unintended consequences in terms of discouraging those who smoke from switching to vaping, which should be further investigated and possibly balanced with other targeted policies to encourage smoking cessation," the authors write.
One author disclosed ties to the pharmaceutical industry.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2025-05-24 06:00
Read more

- Three New Color Food Additives From Natural Sources Approved by FDA
- GLP-1 Receptor Agonists Reduce Alcohol Intake in Patients Treated for Obesity
- AI Three-Item Severity Score Can ID Eczema From Patient-Uploaded Images
- General Practitioners Face Barriers to Treating Patients' Sexual Problems
- Nucala (mepolizumab) Approved by US FDA for Use in Adults with Chronic Obstructive Pulmonary Disease (COPD)
- Medicaid Unwinding Linked to Disruption of Chronic Medication Therapy in Youth
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions